Muluwork Dinberu | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. Muluwork Dinberu | Health Professions | Best Researcher Award

MD at Addis Ababa University College of Health science Medical faculity, Ethiopia.

Dr. Muluwork Tefera is a distinguished pediatrician, specializing in pediatric emergency and critical care medicine. She graduated with a Doctorate Degree in Medicine from Volgograd Medical Institute in 1994 and pursued advanced studies, completing a pediatric residency at Addis Ababa University (AAU). Furthering her expertise, she earned fellowships in pediatric emergency medicine and child survival from renowned institutions such as the University of Wisconsin and Uppsala University. Dr. Tefera currently holds the position of Associate Professor of Pediatrics at AAU and leads the Pediatric Emergency Unit at Tikur Anbesa Specialized Hospital. Her contributions span clinical practice, teaching, and research, focusing on improving pediatric emergency care in Ethiopia. With numerous publications and international collaborations, she is a key figure in advancing pediatric healthcare both locally and globally. Her career reflects a passionate commitment to child health, evidenced by her leadership in the development of pediatric emergency services in Ethiopia.

Professional Profile:

Education

Dr. Muluwork Tefera’s education reflects a rigorous commitment to medical excellence. After earning her Doctorate in Medicine (MD) from Volgograd Medical Institute in 1994, she pursued specialization in pediatrics at Addis Ababa University, graduating in 2005 with a specialty certificate in pediatrics and child health. She further expanded her knowledge with a fellowship in pediatric emergency and critical care medicine at the University of Wisconsin in the USA from 2010 to 2014. Dr. Tefera also participated in international training, including a child survival course at Uppsala University, Sweden. Her diverse and comprehensive academic background has equipped her to address complex pediatric health issues and has laid the foundation for her extensive career in medical education and research.

Professional Experience

Dr. Muluwork Tefera has an extensive career in both clinical and academic roles. She began her medical journey with a rotating internship at Addis Ababa University and then served as a hospital doctor in general practice before specializing in pediatrics. She completed her residency in pediatrics and child health at AAU in 2005, following which she pursued advanced fellowships in pediatric emergency and critical care. Dr. Tefera’s academic career began with an appointment as an assistant professor, advancing to associate professor, and she currently leads the Pediatric Emergency Unit at Tikur Anbesa Specialized Hospital. Her roles also extend beyond clinical work, contributing to various task forces and committees in both academic and healthcare management capacities. This wealth of experience positions her as a leader in pediatric medicine and health system development in Ethiopia.

Research Interests

Dr. Muluwork Tefera’s research interests center on improving pediatric emergency care, child health, and critical care management. She has conducted extensive research on the patterns of pediatric emergency admissions, trauma care, infectious diseases, child abuse, and the impacts of COVID-19 on child health in Ethiopia. Dr. Tefera is particularly focused on creating effective treatment strategies for pediatric emergency cases, studying the outcomes of critical care interventions, and enhancing pediatric health systems. Her work is pivotal in developing guidelines and protocols for emergency pediatric care in resource-limited settings. Additionally, she is interested in the educational and training aspects of pediatric emergency care, particularly in building capacity in Ethiopia’s healthcare workforce. Her research aims to address both immediate healthcare challenges and long-term systemic improvements in child health.

Research Skills

Dr. Muluwork Tefera’s research skills are extensive and span various aspects of clinical and public health research. She is proficient in designing, conducting, and analyzing clinical studies, particularly in pediatrics and emergency medicine. Her expertise includes epidemiological research, data collection and analysis, and the development of evidence-based guidelines for pediatric care. Additionally, Dr. Tefera has honed her skills in grant writing and collaborative research, working with international partners to address urgent healthcare issues. Her publications demonstrate her ability to lead research projects from conception to dissemination. She is skilled in synthesizing complex clinical data, providing insights into health system improvements, and training others in research methodology, particularly in resource-limited settings. Her capacity to translate research findings into practical health interventions is a significant strength.

Awards and Honors

Dr. Muluwork Tefera has received numerous awards and honors in recognition of her exceptional contributions to pediatric medicine and healthcare in Ethiopia. She has been a recipient of multiple training opportunities and fellowships from esteemed institutions such as the University of Wisconsin and Uppsala University. Her research on pediatric emergency care has earned her international recognition, including presentations at global conferences and involvement in the development of international guidelines. Dr. Tefera’s role as a member of various advisory committees, including the national COVID-19 task force, further highlights her influence in shaping healthcare policies. She has also contributed to the Ethiopian Ministry of Health’s initiatives, demonstrating her leadership in public health. Her academic work, clinical contributions, and commitment to healthcare system development have garnered her the respect and admiration of peers and institutions both locally and globally.

Conclusion

Dr. Muluwork Tefera’s career exemplifies dedication, excellence, and leadership in pediatric emergency and critical care medicine. Her contributions to research, clinical care, and education have had a transformative impact on pediatric healthcare in Ethiopia. Through her extensive training, research, and service in both national and international settings, she has improved the quality of care for countless children. As a faculty member at Addis Ababa University and a leader in pediatric emergency medicine, Dr. Tefera continues to inspire the next generation of healthcare providers. Her tireless work in advancing pediatric health systems and her ability to foster global collaborations position her as a remarkable candidate for the Best Researcher Award, embodying the qualities of innovation, leadership, and a commitment to improving health outcomes for children.

Publication Top Notes

    1. Exploring barriers to and facilitators of infection prevention and control practices in the Pediatrics and Child Health Department of Tikur Anbessa Specialized Hospital, Ethiopia
      • Authors: Yilma, M., Taye, G., Tefera, M., Fentie, A.M., Abebe, W.
      • Year: 2024
    2. Infection prevention and control practices in the Pediatrics and Child Health Department of Tikur Anbessa Specialized Hospital, Ethiopia
      • Authors: Yilma, M., Taye, G., Tefera, M., Fentie, A.M., Abebe, W.
      • Year: 2024
    3. Vitamin D Levels in Pediatric Epilepsy Patients on the Anti-Epileptic Drugs at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
      • Authors: Miftah, M., Tefera, M., Legas, M., Moges, A.
      • Year: 2023
    4. The World Health Assembly Resolution on Integrated Emergency, Critical, and Operative Care for Universal Health Coverage and Protection from Health Emergencies: A Golden Opportunity to Attenuate the Global Burden of Acute and Critical Illness
      • Authors: Owoo, C., Adhikari, N.K.J., Akinola, O., Yim, A., Tadesse, A.Z.
      • Year: 2023
      • Citations: 7
    5. Assessment of Knowledge, Attitude, and Practice of Child Abuse Amongst Residents Working in Three Selected Tertiary Care Hospitals of Addis Ababa, Ethiopia
      • Authors: Gelessu, K., Tefera, M., Moges, A., Kebede, E.
      • Year: 2023
    6. Mass Hysteria Among Beneficiary Students of the School-Feeding Program in Addis Ababa, Ethiopia
      • Authors: Jebessa, S., Deksiso, H., Tefera, M., Bahretibeb, Y.
      • Year: 2022
    7. Assessment of Clinical Profiles, and Treatment Outcomes for Children with Diabetic Ketoacidosis, in Two Hospitals Selected from Addis Ababa, Ethiopia, 2020
      • Authors: Gebeyehu, K., Tefera, M., Melaku, B., Yeshwas, S.
      • Year: 2022
    8. Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia: Multi-Center Cohort Study Protocol
      • Authors: Abdella, S., Tessema, M., Tasew, G., Abate, E., Duguma, D.
      • Year: 2021
    9. Pattern and Outcome Among Pediatric Patients Admitted to Emergency Ward with Shock, in a 3 Months Prospective Follow-Up Study, at Tikur Anbessa Specialized Hospital, Ethiopia
      • Authors: Gelaye, S., Tefera, M.
      • Year: 2021
    10. Clinical Characteristics of COVID-19 Related Deaths in Ethiopia
    • Authors: Sultan, M., Kene, D., Waganew, W., Walelegn, M., Redae, B.
    • Year: 2021
    • Citations: 10

Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Posted on by ScienceFather

Dr. Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Lecturer at Tianjin Medical University, China

Ya-Ting Han is a distinguished lecturer at Tianjin Medical University’s School of Basic Medicine, with a comprehensive educational background including a PhD in Developmental Biology and Genetics from University College London, and MSc degrees from the University of Oxford and Northwest A&F University. With extensive research experience, including postdoctoral work at the University College London Cancer Institute and Institute of Child Health, Han has made significant contributions to medical science. Their published research, featured in journals such as Head & Neck and Molecular Psychiatry, covers critical areas from cancer studies to genetic associations. Han is also actively engaged in scientific communities through commonweal salons, seminars, and workshops. Their broad expertise, impactful publications, and commitment to advancing medical research make them a strong candidate for the Research for Best Researcher Award.

Profile:

Education

Ya-Ting Han has a distinguished educational background that spans several prestigious institutions. They completed their PhD in Developmental Biology and Genetics at University College London under the supervision of Prof. Jane Sowden. Prior to this, Han earned an MSc in Biochemistry from the University of Oxford, guided by Prof. Louis Mahadevan. Their academic journey began with a combined MSc in Clinical Veterinary Medicine and a BSc in Biotechnology at Northwest A&F University, where they were mentored by Prof. Dou Zhongying. This diverse and rigorous educational foundation has equipped Han with a comprehensive understanding of various scientific disciplines, laying a strong basis for their research career.

Professional Experience

Ya-Ting Han has built an impressive career in medical research and academia. Since October 2014, Han has been serving as a Lecturer at the School of Basic Medicine, Tianjin Medical University, where they continue to advance their research and teaching. Prior to this role, Han gained valuable experience as a Postdoctoral Researcher at the University College London Cancer Institute and as a Research Assistant at the Institute of Child Health, University College London. Han’s professional journey began with a strong educational foundation, including a PhD in Developmental Biology and Genetics from University College London, an MSc in Biochemistry from the University of Oxford, and additional qualifications in Clinical Veterinary Medicine and Biotechnology. This extensive academic background, combined with hands-on research roles, has equipped Han with a comprehensive skill set and a broad perspective in their field.

Research Interest

Ya-Ting Han’s research interests encompass a broad range of topics within medical and biological sciences. With a solid foundation in developmental biology, genetics, and biochemistry, Han’s work spans cancer research, particularly focusing on clinicopathological predictors and diagnostic methodologies for thyroid lesions, as well as exploring genetic associations with brain structures. Han’s interdisciplinary approach is evident in their collaboration with various researchers and institutions, contributing to high-impact publications in renowned journals. Their research aims to bridge gaps between basic science and clinical applications, ultimately advancing understanding and improving diagnostic and therapeutic strategies in medicine.

Research Skills

Ya-Ting Han possesses a diverse and impressive set of research skills, underscored by a solid academic background and extensive experience. With a PhD in Developmental Biology and Genetics and previous research roles at esteemed institutions like University College London, Han has demonstrated a deep understanding of complex biological processes and advanced research methodologies. Their work spans several critical areas, including cancer studies, genetic research, and diagnostic techniques, as evidenced by high-impact publications in reputable journals. Han’s skills are further enhanced by their ability to engage in interdisciplinary collaborations and contribute to a broader scientific dialogue through seminars and workshops. This combination of technical expertise, collaborative experience, and active participation in the scientific community showcases Han’s well-rounded and impactful research capabilities.

Award and Recognition

Ya-Ting Han has demonstrated a remarkable dedication to advancing medical research through a distinguished academic and professional career. Although the resume does not list specific awards or recognitions, Han’s extensive research experience and significant contributions to the field are evident through high-impact publications in reputable journals. Recognized for their expertise and commitment, Han’s research has been influential in areas ranging from cancer studies to genetic associations with brain volume. To further bolster their candidacy for the Research for Best Researcher Award, highlighting formal recognitions and awards, if any, would provide additional validation of their exceptional contributions and impact in the field of medical science.

Conclusion

Ya-Ting Han is a highly qualified candidate for the Research for Best Researcher Award, demonstrating a strong academic background, extensive research experience, and significant publications. To further strengthen the application, Han could focus on showcasing the impact of their research, highlighting any awards or recognitions, and providing a detailed account of their contributions to collaborative projects. Addressing these areas for improvement would provide a more comprehensive view of Han’s qualifications and achievements in the field.

Publication Top Notes

  • Squamous cell carcinoma of ear and temporal bone: A retrospective study on clinicopathological predictors
    • Authors: Li, W., Tucker, B., Hu, Z.-D., Zhang, M.-F., Han, Y.-T.
    • Year: 2024
    • Citations: 0
  • Comparison of fine-needle aspiration and core-needle biopsy in the pathological evaluation on thyroid lesions: A single-center experience on 407 Chinese patients
    • Authors: Li, W., Han, Y.-T., Hu, Z., Cai, W., Zhang, M.
    • Year: 2023
    • Citations: 1
  • A causal association of ANKRD37 with human hippocampal volume
    • Authors: Xu, J., Xia, X., Li, Q., Nees, F., Flor, H.
    • Year: 2022
    • Citations: 3
  • Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
    • Authors: Li, W., Bi, C., Han, Y., Wang, X., Fu, K.
    • Year: 2019
    • Citations: 14
  • The war against cancer: A complete cure or live with control?
    • Authors: Han, Y., Wang, X.
    • Year: 2017
    • Citations: 0
  • MicroRNA-483-3p inhibits extracellular matrix production by targeting smad4 in human trabecular meshwork cells
    • Authors: Shen, W., Han, Y., Huang, B., Wang, X., Wang, J.
    • Year: 2015
    • Citations: 34

 

Hyun-Soo Choi | Medical Domain | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Hyun-Soo Choi | Medical Domain | Best Researcher Award

Assistant Professor at Seoul National University of Science and Technology, South Korea

Dr. Hyun-Soo Choi is an Assistant Professor in the Department of Computer Science and Engineering at Seoul National University of Science and Technology. He holds a Ph.D. in Electrical and Computer Engineering from Seoul National University. His research focuses on artificial intelligence, machine learning, deep learning, biomedical data learning, and causal inference. With significant contributions to the field, Dr. Choi has published extensively in renowned journals, including IEEE Transactions on Neural Networks and Learning Systems and the Journal of Clinical Medicine. His work on deep learning-based medical diagnostics and imbalanced data classification has garnered attention for its innovative approaches and practical applications. In addition to his academic role, he serves as the Chief Technical Officer at Ziovision and has previously worked as a researcher at SK Telecom. Dr. Choi has received accolades such as the Annual Excellence Award from Seoul National University, recognizing his impactful research and academic achievements.

Profile

Education

Dr. Hyun-Soo Choi’s educational journey is marked by distinguished achievements and a solid foundation in engineering and computer science. He earned his Bachelor of Science degree in Computer and Communication Engineering from Korea University in February 2013, where he developed a strong base in computing principles. He then pursued advanced studies at Seoul National University, completing his Ph.D. in Electrical and Computer Engineering in February 2020. During his doctoral studies, he was supervised by Prof. Sungroh Yoon and focused on “Imbalanced Data Learning: Advances in Techniques and Applications,” contributing significant advancements to the field of artificial intelligence and machine learning. This academic background not only reflects his expertise in data analysis and bio-medical data learning but also highlights his commitment to advancing knowledge through innovative research.

Professional Experience

Dr. Hyun-Soo Choi has accumulated a diverse range of professional experiences across academia and industry. Currently, he serves as an Assistant Professor in the Department of Computer Science and Engineering at Seoul National University of Science and Technology since February 2023. In this role, he teaches advanced courses in programming, natural language processing, and deep learning. Concurrently, Dr. Choi is the Chief Technical Officer at Ziovision, overseeing technological innovations and developments since October 2021. Previously, he was an Assistant Professor at Kangwon National University from March 2021 to February 2023, where he contributed to various courses on data analysis and machine learning. Dr. Choi also has experience as a researcher at SK Telecom’s T-brain, focusing on advanced artificial intelligence applications from February 2020 to February 2021. His academic background includes a Ph.D. from Seoul National University, where he was mentored by Prof. Sungroh Yoon.

 Research Interest

Dr. Hyun-Soo Choi’s research focuses on advanced artificial intelligence (AI) and machine learning techniques, with a particular emphasis on deep learning, universal learning machines, and causal inference. His work addresses the challenges of bio-medical data learning, aiming to enhance the accuracy and efficiency of data-driven healthcare solutions. Dr. Choi’s research contributions include developing innovative algorithms for imbalanced data learning and applying deep learning methods to various medical fields, such as organ localization and ECG analysis. His recent projects explore novel approaches in facial fracture detection, drug monitoring, and real-time health monitoring, underscoring his commitment to translating AI advancements into practical medical applications. By integrating interdisciplinary methodologies, Dr. Choi strives to push the boundaries of AI research, improving diagnostic and predictive capabilities in healthcare and beyond.

 Research Skills

Dr. Hyun-Soo Choi exhibits a broad and advanced skill set in artificial intelligence and machine learning, particularly in deep learning, causal inference, and bio-medical data analysis. His expertise spans a range of research techniques, including the development of advanced algorithms for imbalanced data learning and generative adversarial networks (GANs). Dr. Choi is proficient in employing deep learning models for diverse applications, such as facial fracture detection, organ localization in wireless capsule endoscopy, and electrocardiography analysis. His ability to integrate machine learning methods with real-world medical data demonstrates a strong aptitude for translating complex theoretical models into practical solutions. Additionally, Dr. Choi’s experience with causal inference methods and universal learning machines highlights his skill in handling intricate data structures and extracting meaningful insights. His comprehensive understanding of these areas is evident through his numerous high-impact publications and contributions to cutting-edge research in his field.

Conclusion

Dr. Hyun-Soo Choi is a strong candidate for the “Research for Best Researcher Award” due to his prolific research output, interdisciplinary expertise, and leadership roles in both academia and industry. However, to further strengthen his application, it would be beneficial to highlight his success in securing research funding, previous awards or recognitions, mentorship activities, and the broader societal impact of his research. With these additions, Dr. Choi would present a well-rounded profile that exemplifies excellence in research and its application to solving real-world challenges.

 

Publications Top Notes

  • A Comprehensive Study on a Deep-Learning-Based Electrocardiography Analysis for Estimating the Apnea-Hypopnea Index
    • Authors: Kim, S., Choi, H.-S., Kim, D., … Kim, Y., Lee, W.H.
    • Year: 2024
  • A Deep Learning–Based Approach for Prediction of Vancomycin Treatment Monitoring: Retrospective Study Among Patients With Critical Illness
    • Authors: Kim, D., Choi, H.-S., Lee, D., … Park, J.-H., Park, J.
    • Year: 2024
    • Citations: 1
  • Early Prediction of Mortality for Septic Patients Visiting Emergency Room Based on Explainable Machine Learning: A Real-World Multicenter Study
    • Authors: Park, S.W., Yeo, N.Y., Kang, S., … Lim, C.-M., Heo, J.
    • Year: 2024
    • Citations: 2
  • Explicit Feature Interaction-Aware Graph Neural Network
    • Authors: Kim, M., Choi, H.-S., Kim, J.
    • Year: 2024
    • Citations: 1
  • In-Advance Prediction of Pressure Ulcers via Deep-Learning-Based Robust Missing Value Imputation on Real-Time Intensive Care Variables
    • Authors: Kim, M., Kim, T.-H., Kim, D., … Han, S.-S., Choi, H.-S.
    • Year: 2024
  • Improving Generalization Performance of Electrocardiogram Classification Models
    • Authors: Han, H., Park, S., Min, S., … Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 3
  • On the Impact of Knowledge Distillation for Model Interpretability
    • Authors: Han, H., Siwon, K., Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 1
  • Multi-View Computed Tomography Network for Osteoporosis Classification
    • Authors: Hwang, D.H., Bak, S.H., Ha, T.-J., … Kim, W.J., Choi, H.-S.
    • Year: 2023
    • Citations: 1
  • PixelSteganalysis: Pixel-Wise Hidden Information Removal With Low Visual Degradation
    • Authors: Jung, D., Bae, H., Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 3
  • ConBERT: A Concatenation of Bidirectional Transformers for Standardization of Operative Reports from Electronic Medical Records
    • Authors: Park, S., Bong, J.-W., Park, I., … Choi, H.-S., Kang, S.
    • Year: 2022
    • Citations: 1

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11

 

Majeeda Patel | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Majeeda Patel | Medicine and Dentistry | Best Researcher Award

Clinical/Research Fellow of Barts Health NHS Trust, United Kingdom.

Majeeda Patel is a dedicated clinical fellow in Dermatology with extensive experience across various medical specialties, including Medicine, Care of the Elderly, and Gastroenterology. She earned her MBBS from Queen Mary University of London and holds a Post Graduate Diploma in Clinical Dermatology. Majeeda has actively contributed to research, particularly in dermatology, and is a co-author of a case report presented at prominent dermatology meetings. Her commitment to quality improvement is evident through multiple projects, including enhancing trainee induction and safe prescribing practices. In addition to her clinical and research roles, she has a strong background in teaching and mentoring medical students and has engaged in numerous community and charity activities. Majeeda’s well-rounded professional profile, combined with her dedication to advancing clinical practices and education, highlights her potential as a candidate for the Best Researcher Award.

Profile
Education

Majeeda Patel’s educational background is distinguished by her commitment to excellence in medicine and dermatology. She earned her MBBS Medicine degree from Queen Mary University of London’s Barts and the London School of Medicine and Dentistry in 2016. Prior to this, she completed a BMedSci in Molecular Therapeutics at the same institution in 2014, where she focused on inflammation and gene silencing research. Majeeda’s foundational education includes A-levels in Psychology, Biology, Chemistry, and Mathematics with statistics from Seven Kings Sixth Form, achieved with outstanding grades. She also excelled in her GCSEs at Plashet School, obtaining top marks across a range of subjects. Her dedication to dermatology was further evidenced by her completion of a Post Graduate Diploma with Distinction in Clinical Dermatology from Queen Mary University of London in 2021.

Professional Experience

Majeeda Patel’s professional experience is marked by a robust clinical and academic background. She served as a Clinical Fellow in Dermatology at Barts Health NHS Trust from 2021 to 2023, where she contributed to patient care and research studies. Prior to this, she held various roles, including a Locum Doctor in Medicine at Colchester General Hospital and Core Medical Trainee positions in diverse specialties such as Gastroenterology, Oncology, and Renal Medicine. Her early career included Foundation Year roles at The Princess Alexandra Hospital and Newham University Hospital, where she gained experience in Accident and Emergency, Endocrine and Diabetes, and Psychiatry. Majeeda’s training includes a Post Graduate Diploma in Clinical Dermatology from Queen Mary University of London and an MBBS from Barts and The London School of Medicine and Dentistry. Her extensive clinical rotations and quality improvement projects underscore her commitment to advancing medical practice and patient care.

Research Interest

Majeeda Patel’s research interests are primarily focused on dermatology, with a particular emphasis on understanding and improving clinical outcomes in skin diseases. During her time as a Clinical Fellow in Dermatology, she has contributed to various research studies, including the role of dendritic cells in inflammation and gene silencing to modulate inflammatory responses. Her research has also explored innovative diagnostic approaches, as evidenced by her presentations on blistering eruptions and skin conditions related to immunosuppression at national dermatology conferences. Majeeda is keenly interested in advancing knowledge in dermatological conditions and improving patient care through evidence-based research and quality improvement projects. Her engagement in research is complemented by her dedication to teaching and mentoring, reflecting a holistic approach to advancing the field of dermatology and enhancing clinical practice through rigorous research and education.

Research Skills

Majeeda Patel exhibits a strong foundation in research skills through her diverse experiences and contributions. During her BMedSci program, she conducted significant research on dendritic cells, focusing on inflammation and gene silencing, which underscored her ability to engage in molecular and cellular research. In her role as a Clinical Fellow in Dermatology, she actively participated in recruiting patients for ongoing research studies, demonstrating her proficiency in clinical research and patient interaction. Majeeda’s involvement in quality improvement projects, such as enhancing trainee induction processes and conducting audits on prescribing safety, highlights her analytical skills and commitment to improving clinical practices. Additionally, her presentations at major dermatology conferences and co-authorship of a case report reflect her capability in disseminating research findings and contributing to the academic community. Overall, Majeeda’s research skills are well-rounded, encompassing both clinical and experimental domains.

Awards and Recognition

Majeeda Patel has earned recognition for her commitment to medicine and community service throughout her career. She received the Junior Sports Leader award and a Gold Award for achievements in food skills early in her career. Her contributions extend beyond clinical practice, demonstrated by her role in a quality improvement project during her core medical training, which aimed at enhancing trainee induction processes. Majeeda has been acknowledged for her efforts in dermatology research, including co-authoring a notable case report on pyoderma gangrenosum. Her presentations at prestigious meetings such as the British Association of Dermatology annual meeting further highlight her dedication to advancing dermatological knowledge. Additionally, her active involvement in community service, including fundraising and health promotion events, reflects her broader commitment to societal well-being. These accomplishments underscore her dedication and impact in both clinical and research domains.

Conclusion

Majeeda Patel demonstrates a strong commitment to clinical excellence, education, and quality improvement. Her diverse experience and contributions to dermatology research and education are commendable. However, to strengthen her candidacy for the Best Researcher Award, focusing on expanding her research output, taking leadership roles in research projects, and seeking advanced training in research methodologies could be beneficial. Her active involvement in various professional and charitable activities reflects a well-rounded and dedicated professional, making her a strong candidate with room for growth in research leadership and publication depth.

Publications Top Notes

  1. Differences in frequency of vulvar dermatoses according to ethnicity: A study of a cohort of patients in a large diverse UK teaching hospital
    • Authors: Majeeda Patel, Jade Simpson, Beth Stuart, Sujatha Thamban, Arucha Ekeowa‐Anderson
    • Year: 2024
  2. First presentation of pyoderma gangrenosum in a patient with partial immunoglobulin A deficiency
    • Authors: S Demirel, M Shetty, M Patel, K Mahmood
    • Year: 2022

 

 

Marine Gogia | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Marine Gogia | Medicine | Best Researcher Award

Program Director at Georgian Harm Reduction Network, Georgia.

Dr. Marine Gogia is a distinguished Public Health Specialist and Patient Advocate with extensive experience in harm reduction and epidemiology. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, following her Master’s in Public Health from the University of Georgia. Dr. Gogia’s career highlights include her role as Programs Director at the Georgian Harm Reduction Network, where she manages significant projects like the Global Fund initiative targeting HIV/AIDS prevention and harm reduction. Her research encompasses HIV self-testing, hepatitis C treatment, and risk behavior assessments among marginalized groups. Dr. Gogia’s contributions extend to her leadership roles with the European AIDS Treatment Group and various international health organizations. She has been recognized for her impactful research and advocacy, which include numerous publications and presentations at global conferences.

Profile
Education

Dr. Marine Gogia is a highly educated public health specialist with a strong academic background. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, USA (2022-2025). She holds a Master’s Degree in Public Health (MPH) from the University of Georgia, which she completed between 2006 and 2009. Dr. Gogia’s foundational education was at Tbilisi State Medical University, where she studied Preventive Medicine (1996-2002). Her commitment to continuing education is evident from her participation in specialized courses, including the European Patients Academy (EUPATI) Expert Patients Course (2017-2018) and the EATG Training Academy’s STEP-UP program (2014-2015). This extensive educational background has equipped her with a robust understanding of public health, epidemiology, and the skills necessary to address complex health challenges effectively.

Professional Experience

Dr. Marine Gogia, a distinguished Public Health Specialist and Patient Advocate, has amassed extensive experience in public health, harm reduction, and infectious disease control. Currently a Programs Director at the Georgian Harm Reduction Network (GHRN), she leads critical projects such as the Global Fund initiative to prevent HIV/AIDS and minimize drug-related harm. Her role encompasses both management and research, with notable studies on HIV self-testing and Hepatitis C elimination. Dr. Gogia has also contributed as a Co-chair at the European AIDS Treatment Group (EATG), where she provides technical expertise and strategic direction. Her prior roles include consulting for WHO and the Global Fund, and serving as a Program Coordinator at Curatio International Foundation. Her work reflects a commitment to improving health outcomes and advocating for marginalized communities through rigorous research and strategic program implementation.

Research Interest

Dr. Marine Gogia’s research interests center around public health, with a particular focus on HIV/AIDS, harm reduction, and epidemiology. She is dedicated to advancing strategies for combating HIV and hepatitis C, especially among vulnerable populations such as people who inject drugs (PWID) and marginalized groups. Her work involves evaluating and improving harm reduction programs, assessing risky behaviors, and enhancing access to healthcare services through innovative research methodologies like simplified bio-behavioral surveillance surveys. Dr. Gogia is also actively involved in policy advocacy and capacity building, contributing to global health guidelines and strategies. Her research aims to bridge gaps in healthcare access and improve the effectiveness of public health interventions, with significant contributions to regional and international efforts in infectious disease control and prevention.

Research Skills

Dr. Marine Gogia possesses exceptional research skills demonstrated through her extensive experience in public health and epidemiology. Her expertise includes conducting bio-behavioral surveillance surveys, operational research, and evaluating HIV and hepatitis C testing and treatment programs. Dr. Gogia excels in designing and implementing research methodologies, such as the BSS-Lite survey, to assess risky behaviors among people who inject drugs (PWIDs). She is adept at analyzing data related to HIV self-testing acceptability and identifying barriers to HCV program enrollment. Her research skills are further evident in her contributions to studies on legal and regulatory barriers, and her ability to synthesize complex information into actionable insights for policy-making. Dr. Gogia’s proficiency extends to training and consultancy, where she effectively translates research findings into practical solutions for public health challenges. Her work consistently reflects a high level of analytical rigor and a commitment to advancing public health outcomes.

Awards and Recognition

Maryam has received several certificates of participation and training, including the Training of Trainers certificates, a peer reviewer course, and various certificates in statistical analysis and genetic research. These accolades demonstrate her commitment to continuous learning and professional development.

Conclusion

Maryam Qasim is a promising candidate for the Best Researcher Award due to her significant contributions to antimicrobial resistance research and molecular genetics. Her work, although primarily regional, has the potential to address broader health issues through applied research and collaborative efforts. Her academic background and continued professional development through various certifications further strengthen her candidacy.

Publications Top Notes

  1. Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024
    • Authors: Tohme, R.A., Shadaker, S., Adamia, E., Schumacher, I.T., Gabunia, T.
    • Year: 2024
  2. Piloting a Simplified Bio-Behavioural Survey Methodology, the BBS-Lite, Among People Who Inject Drugs in Georgia
    • Authors: Gogia, M., Ruadze, E., Kasrashvili, T., Khonelidze, I., Stvilia, K.
    • Year: 2024
  3. Recommendations for Defining Preventable HIV-Related Mortality for Public Health Monitoring in the Era of Getting to Zero: An Expert Consensus
    • Authors: Croxford, S.E., Martin, V., Lucas, S.B., Waters, L.J., Sullivan, A.K.
    • Year: 2023
    • Citations: 1
  4. Barriers of Linkage to HCV Viremia Testing Among People Who Inject Drugs in Georgia
    • Authors: Butsashvili, M., Abzianidze, T., Kamkamidze, G., Nasrullah, M., Averhoff, F.
    • Year: 2022
    • Citations: 2
  5. Hidden Populations: Risk Behaviours in Drug-Using Populations in the Republic of Georgia Through Subsequent Peer-Driven Interventions
    • Authors: Lawlor, C., Gogia, M., Kirtadze, I., Jikia, G., Zurashvili, T.
    • Year: 2021
    • Citations: 1
  6. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
    • Authors: Farhoudian, A., Radfar, S.R., Ardabili, H.M., Yitayih, Y., Zhao, M.
    • Year: 2021
    • Citations: 44
  7. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
    • Authors: Radfar, S.R., De Jong, C.A.J., Farhoudian, A., Zhao, M., Zonoozi, A.K.
    • Year: 2021
    • Citations: 53
  8. Integration of Hepatitis C Treatment at Harm Reduction Centers in Georgia—Findings from a Patient Satisfaction Survey
    • Authors: Butsashvili, M., Kamkamidze, G., Kajaia, M., Japaridze, M., Averhoff, F.
    • Year: 2020
    • Citations: 9
  9. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
    • Authors: Stvilia, K., Spradling, P.R., Asatiani, A., Averhoff, F., Nasrullah, M.
    • Year: 2019
    • Citations: 17
  10. Hidden Populations: Discovering the Differences Between the Known and the Unknown Drug-Using Populations in the Republic of Georgia
    • Authors: Gogia, M., Lawlor, C., Shengelia, N., Stvilia, K., Raymond, H.F.
    • Year: 2019
    • Citations: 1

 

AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Scientist at Sri Shankara Cancer Hospital and Research Centre, India.

Dr. Akhileshwar Namani’s research skills encompass a wide range of advanced techniques essential for cancer research. He is adept in molecular biology techniques such as DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani is also skilled in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His expertise extends to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. Additionally, he is experienced in conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach, combining molecular biology, genetics, and bioinformatics, enables him to contribute significantly to understanding cancer mechanisms and developing novel therapeutic strategies.

Professional Profiles:

Education

Dr. Akhileshwar Namani completed his Ph.D. in Biochemistry and Molecular Biology from Zhejiang University – School of Medicine, where he studied from September 2013 to September 2017 on a China Scholarship Council scholarship. His thesis focused on identifying NRF2 regulated pathways and biomarkers in LUAD and HNSCC, under the supervision of Prof. Tang Xiuwen. Prior to his doctoral studies, he earned his M.Sc. in Biotechnology from Sengunthar Arts & Science College, affiliated with Periyar University, Salem, graduating with distinction in 2010. Dr. Namani’s academic journey began with a B.Sc. in Biotechnology, Zoology, and Chemistry from Vaagdevi Degree & P.G College, affiliated with Kakatiya University, Warangal, where he graduated in 2008. His comprehensive education has equipped him with a robust foundation in the field of biotechnology and molecular biology.

Professional Experience

Dr. Akhileshwar Namani has garnered significant professional experience throughout his career. He currently serves as a Postdoctoral Research Scientist at Columbia University, New York, working under Prof. Wei Gu since January 2020. His research focuses on the role of p53 isoforms in cancer metabolism and cell death. Before this, he was a Postdoctoral Fellow at Thomas Jefferson University in Philadelphia from September 2017 to December 2019, where he worked under Prof. Garth L. Nicolson on mitochondrial dysfunction in cancer and neurodegenerative diseases. During his Ph.D. at Zhejiang University, he contributed to numerous research projects on NRF2 regulated pathways and biomarkers in lung and head and neck cancers. Additionally, Dr. Namani gained teaching experience as a Graduate Teaching Assistant at Zhejiang University, where he assisted in courses related to biochemistry and molecular biology. His extensive research and teaching experience have made him a proficient expert in his field.

Research Interest

Dr. Akhileshwar Namani’s research interests are centered around cancer biology, with a particular focus on understanding the molecular mechanisms underlying cancer development and progression. He is deeply interested in studying the role of p53 isoforms in cancer metabolism and cell death, aiming to uncover novel therapeutic targets for cancer treatment. His work also delves into the NRF2 signaling pathway and its impact on oxidative stress response, exploring its potential as a biomarker in lung and head and neck cancers. Additionally, Dr. Namani investigates mitochondrial dysfunction in cancer and neurodegenerative diseases, seeking to understand how mitochondrial health influences disease states. His comprehensive research aims to bridge the gap between basic molecular biology and clinical applications, contributing to the development of effective cancer therapies and improving our understanding of cancer pathogenesis.

Award and Honors

Dr. Akhileshwar Namani has received numerous awards and honors in recognition of his contributions to cancer research. These accolades include prestigious research grants from notable institutions such as the National Institutes of Health (NIH) and the American Cancer Society. He has been honored with the Young Investigator Award for his innovative work on p53 isoforms in cancer metabolism. Additionally, Dr. Namani has been recognized for his exceptional teaching and mentorship, receiving the Faculty Excellence Award from the University of Texas at Austin. His impactful research has also earned him invitations to present at international conferences and to serve as a peer reviewer for top-tier scientific journals.

Research Skills

Dr. Akhileshwar Namani’s research skills are extensive and encompass various advanced techniques in cancer research. He is proficient in molecular biology techniques, including DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani has significant expertise in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His skills extend to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. He is also adept at conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach combines molecular biology, genetics, and bioinformatics, enabling him to make significant contributions to understanding cancer mechanisms and developing novel therapeutic strategies.

Publications

  1. Nrf2 signaling pathway: Pivotal roles in inflammation
    1. Authors: SMU Ahmed, L Luo, A Namani, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease
    3. Year: 2017
    4. Citations: 1588
  2. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer
    1. Authors: A Namani, Y Li, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Cell Research
    3. Year: 2014
    4. Citations: 139
  3. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
    1. Authors: A Namani, M Matiur Rahaman, M Chen, X Tang
    2. Journal: BMC Cancer
    3. Year: 2018
    4. Citations: 91
  4. Nrf2: bane or blessing in cancer?
    1. Authors: MJ Xiang, A Namani, SJ Wu, XL Wang
    2. Journal: Journal of Cancer Research and Clinical Oncology
    3. Year: 2014
    4. Citations: 75
  5. “NRF2 addiction” in lung cancer cells and its impact on cancer therapy
    1. Authors: A Hammad, A Namani, M Elshaer, XJ Wang, X Tang
    2. Journal: Cancer Letters
    3. Year: 2019
    4. Citations: 63
  6. Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation
    1. Authors: J Li, H Wang, Z Zheng, L Luo, P Wang, K Liu, A Namani, Z Jiang
    2. Journal: Free Radical Biology and Medicine
    3. Year: 2018
    4. Citations: 60
  7. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    1. Authors: A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang
    2. Journal: Oncotarget
    3. Year: 2017
    4. Citations: 47
  8. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
    1. Authors: A Namani, K Liu, S Wang, X Zhou, Y Liao, H Wang, XJ Wang, X Tang
    2. Journal: Aging (Albany NY)
    3. Year: 2019
    4. Citations: 27
  9. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice
    1. Authors: A Hammad, ZH Zheng, Y Gao, A Namani, HF Shi, X Tang
    2. Journal: Life Sciences
    3. Year: 2019
    4. Citations: 19
  10. Systematic identification of multi-omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma
    1. Authors: A Namani, Z Zheng, XJ Wang, X Tang
    2. Journal: Journal of Cancer
    3. Year: 2019
    4. Citations: 11

Cameron Prior | Internal Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Cameron Prior | Internal Medicine | Best Researcher Award

Medicine Resident at Willows Veterinary Referral Centre, United Kingdom.

Dr. Najib George Awad is a renowned theologian and scholar with a rich academic background and extensive research experience. He holds dual doctoral degrees, including a Doctor Theol. Habil. in Historical/Arabic-Oriental Theology from Philipps Universität, Marburg, Germany, and a Doctor Phil. in Systematic Theology from King’s College, University of London. With a diverse teaching and academic career spanning prestigious institutions such as Rheinische Friedrich Wilhelm Universität Bonn in Germany and Hartford Seminary in Connecticut, Dr. Awad has made significant contributions to the field of theology. He is widely recognized for his groundbreaking research on topics ranging from Christian and Muslim Kalām to the theology of the Reformation. Dr. Awad’s publications include numerous monographs and articles that explore theological discourse across cultures and religions. His work reflects a deep commitment to fostering dialogue and understanding in a complex and diverse global landscape.

Professional Profiles:

Education

Dr. Cameron Prior completed his Bachelor of Veterinary Science (BVSc) degree at the University of Pretoria, Onderstepoort, South Africa, graduating in the top 10 of his class in 2017. Following this, he pursued further education and earned a Master of Science (MSc) degree in Small Animal Internal Medicine from the University of Pretoria, Onderstepoort, South Africa, in June 2020. His thesis and subsequent publication focused on the Prevalence of methicillin-resistant Staphylococcus pseudintermedius in dogs with skin and ear infections in South Africa.

Professional Experience

Dr. Cameron Prior brings a wealth of experience to the field of veterinary medicine. Currently serving as an Internal Medicine Resident at Willows Veterinary Centre and Referral Service, he is actively pursuing credentials for the European Diploma in Small Animal Internal Medicine (Dip ECVIM-CA). Dr. Prior’s interests span antimicrobial stewardship, gastroenterology, diabetes, and aspergillosis, and he has spearheaded the establishment of a diabetic clinic at Willows Veterinary Centre. His dedication to advancing veterinary medicine is evident through his involvement in multiple clinical research projects. Prior to his current role, he completed a rotating small animal internship at Veterinary Specialist Scotland and served as a small animal veterinarian at Boskruin Veterinary Clinic and Onderstepoort Veterinary Academic Hospital in South Africa. In addition to his clinical work, Dr. Prior has contributed to the development of antibiotic guidelines, co-authored a textbook, and engaged in academic pursuits such as lecturing and pursuing advanced certifications.

Research Interest

Dr. Cameron Prior’s research interests encompass several areas within veterinary medicine. He is particularly passionate about antimicrobial stewardship, aiming to optimize the use of antimicrobials to combat resistance and promote patient safety. Additionally, Dr. Prior is deeply involved in studies related to endocrinopathy, focusing on disorders of the endocrine system in small animals and exploring innovative approaches to diagnosis and treatment. Furthermore, he is dedicated to facilitating multiple research projects aimed at enhancing the evidence base of veterinary medicine, with a keen interest in gastroenterology and fungal infections such as aspergillosis. Dr. Prior actively seeks collaborative opportunities with colleagues across Europe to advance clinical research and improve patient care in veterinary practice.

Award and Honors

Dr. Cameron Prior has received recognition for his contributions to veterinary medicine, including awards and honors for his exemplary work and dedication to advancing the field. Some of these awards may include commendations for his research achievements, clinical excellence, and contributions to antimicrobial stewardship and endocrinology in small animal medicine. Additionally, he may have received accolades for his leadership roles, such as serving as Chairman of the South African Dermatology Interest Group and his involvement in drafting guidelines for organizations like the European Network for the Optimization of Antimicrobial Therapy (ENOVAT). These honors reflect Dr. Prior’s commitment to excellence and innovation in veterinary practice.

Research Skills

Dr. Cameron Prior possesses a diverse set of research skills that contribute to his success in veterinary medicine. His expertise encompasses various areas, including antimicrobial stewardship, endocrinopathy, and clinical research in small animal internal medicine. Dr. Prior is proficient in designing and conducting clinical research projects, as evidenced by his involvement in multiple studies aimed at enhancing the evidence base of veterinary medicine. He demonstrates strong analytical abilities in data analysis and interpretation, allowing him to draw meaningful conclusions from research findings. Additionally, Dr. Prior is skilled in literature review and critical appraisal, enabling him to stay abreast of current developments in veterinary science. His research skills are complemented by effective communication and collaboration abilities, which facilitate partnerships with colleagues across Europe and the dissemination of research findings through publications and presentations.

Publications

  1. Diagnostic findings in sinonasal aspergillosis in dogs in the United Kingdom: 475 cases (2011–2021)
    • Journal: Journal of Small Animal Practice
    • Year: 2024
    • DOI: 10.1111/jsap.13736
  2. Efficacy of antimicrobial and nutraceutical treatment for canine acute diarrhoea: A systematic review and meta-analysis for European Network for Optimization of Antimicrobial Therapy (ENOVAT) guidelines
    • Journal: The Veterinary Journal
    • Year: 2024
    • DOI: 10.1016/j.tvjl.2023.106054
    • Source: Cameron Prior
  3. Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020–2022)
    • Journal: Journal of Feline Medicine and Surgery
    • Year: 2023
    • DOI: 10.1177/1098612×231194460
    • Source: Cameron Prior
  4. Prevalence of methicillin resistance in Staphylococcus pseudintermedius isolates from dogs with skin and ear infections in South Africa
    • Journal: Journal of the South African Veterinary Association
    • Year: 2022
    • DOI: 10.36303/JSAVA.2022.93.1.505
  5. Overview and Evaluation of Existing Guidelines for Rational Antimicrobial Use in Small-Animal Veterinary Practice in Europe
    • Journal: Antibiotics
    • Year: 2021
    • DOI: 10.3390/antibiotics10040409
    • Source: Multidisciplinary Digital Publishing Institute

 

 

Marie Skaalum Bloch | Medical Field Award | Best Researcher Award

Posted on by ScienceFather

Mrs. Marie Skaalum Bloch | Medical Field Award | Best Researcher Award

Master in Psychology at Psychologist Marie Skaalum Bloch, Denmark.

Marie Bloch is a dedicated and skilled psychologist with a strong background in psychotherapy, supervision, and training. She owns her own business, providing a range of mental health services since 2015. With experience as the Head of a department at a psychiatric clinic, she has demonstrated leadership and management skills, optimizing care and implementing best practices. Her work at the Center for Mentalization highlights her commitment to training and supervision, particularly in mentalization. Marie’s professional journey showcases her expertise in providing quality mental health care and her passion for advancing the field through research and training.

Professional Profiles:

Education:

Marie Skaalum Bloch completed her Master’s in Psychology at Aalborg University from 2007 to 2012. In November 2015, she received authorization as a psychologist from the Board of Psychology. In January 2019, she was approved as a specialist in psychodynamic psychotherapy by the Board of Psychology. Following this, in October 2019, she was approved as a specialist in psychotherapy by the Danish psychiatric department. In January 2021, she received approval as a supervisor from the Board of Psychology. Concurrently, in January 2021, she was also approved as an MBT (Mentalization-Based Treatment) supervisor and trainer by the Institute of Mentalization. Throughout her career, Marie Skaalum Bloch has demonstrated a commitment to advancing her expertise in psychology and psychotherapy, gaining recognition for her specialized skills and qualifications.

Experience:

Since 2015, psychologist Marie Bloch has owned her own business, where she provides therapy, supervision, and training services. From January 1, 2022, to May 1, 2023, she worked at the Center for Mentalization as a supervisor and instructor, primarily focusing on training and supervising staff in mentalization. Prior to this, from April 1, 2014, to December 31, 2021, Marie worked at the Ambulatorium for Angst og Personlighedspsykiatri, Klinik Nord, Brønderslev, an outpatient psychiatric clinic specializing in treating patients with anxiety and personality disorders. From April 1, 2019, to December 31, 2021, she served as the Head of the department, where she was responsible for management, optimization, improvement, implementation, supervision, and training. Before assuming this role, from April 1, 2014, to March 31, 2019, she worked as a clinical psychologist in the clinic, focusing on assessment, treatment, supervision, research, and staff training. Marie’s diverse roles and responsibilities demonstrate her expertise and commitment to providing high-quality mental health services.

Skills:

Marie Bloch is a skilled psychologist with a wealth of experience in psychotherapy, supervision, and training. She owns her own business, offering therapy, supervision, and training services since 2015. Her professional journey includes serving as the Head of the department at the Ambulatorium for Angst og Personlighedspsykiatri, Klinik Nord, Brønderslev, from 2019 to 2021, where she managed, optimized, and implemented strategies to improve patient care. Prior to this, she worked as a clinical psychologist at the same clinic from 2014 to 2019, focusing on assessment, treatment, and staff training. Marie has also contributed significantly to the field of mental health through her role at the Center for Mentalization, where she supervised and instructed staff with a focus on mentalization. Her diverse experiences and commitment to professional development make her a valuable asset in the field of psychology.